• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有同步肝转移的乳腺癌早期死亡的预测模型:一项基于人群的研究。

A Predictive Model for the Early Death of Breast Cancer With Synchronous Liver Metastases: A Population-Based Study.

机构信息

Department of Oncology, The Second Hospital of Anhui Medical University, Hefei, China.

Shenzhen Clinical Medical School of Southern Medical University.

出版信息

Cancer Control. 2023 Jan-Dec;30:10732748231202851. doi: 10.1177/10732748231202851.

DOI:10.1177/10732748231202851
PMID:37724916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10510350/
Abstract

BACKGROUND

Breast cancer liver metastasis (BCLM) is a severe condition often resulting in early death. The identification of prognostic factors and the construction of accurate predictive models can guide clinical decision-making.

METHODS

A large sample of data from the Surveillance, Epidemiology, and End Results (SEER) database was analyzed, including 3711 patients diagnosed with de novo BCLM between 2010 and 2015. Predictive models were developed using histograms, and stepwise regression addressed variable collinearity. Internal validation was performed, and results were compared to similar studies.

RESULTS

In this study of 3711 BCLM patients, 2571 didn't have early death. Out of the 1164 who died early, 1086 had cancer-specific early death. Prognostic factors for early death, including age, race, tumor size, and lymph node involvement, were identified. A nomogram based on these factors was constructed, accurately predicting early all-cause and cancer-specific death.

CONCLUSIONS

Valuable insights into the prognosis of BCLM patients were provided, and important prognostic factors for early death were identified. The developed nomogram can assist clinicians in identifying high-risk patients for early death and inform treatment decisions.

摘要

背景

乳腺癌肝转移(BCLM)是一种严重的疾病,常导致早期死亡。识别预后因素并构建准确的预测模型可以指导临床决策。

方法

对来自监测、流行病学和最终结果(SEER)数据库的大量数据进行分析,包括 2010 年至 2015 年间诊断为初发性 BCLM 的 3711 例患者。使用直方图开发预测模型,并采用逐步回归解决变量共线性问题。进行内部验证,并将结果与类似研究进行比较。

结果

在这项对 3711 例 BCLM 患者的研究中,2571 例患者没有早期死亡。在 1164 例早期死亡的患者中,有 1086 例死于癌症特异性原因。确定了早期死亡的预后因素,包括年龄、种族、肿瘤大小和淋巴结受累。基于这些因素构建了一个列线图,能够准确预测早期全因和癌症特异性死亡。

结论

本研究为 BCLM 患者的预后提供了有价值的见解,并确定了早期死亡的重要预后因素。开发的列线图可以帮助临床医生识别早期死亡风险较高的患者,并为治疗决策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/19c1fea28c6d/10.1177_10732748231202851-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/1bf7df923cb1/10.1177_10732748231202851-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/98aaa6752c78/10.1177_10732748231202851-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/443d5b2574f5/10.1177_10732748231202851-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/12211d8d7417/10.1177_10732748231202851-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/19c1fea28c6d/10.1177_10732748231202851-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/1bf7df923cb1/10.1177_10732748231202851-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/98aaa6752c78/10.1177_10732748231202851-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/443d5b2574f5/10.1177_10732748231202851-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/12211d8d7417/10.1177_10732748231202851-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e408/10510350/19c1fea28c6d/10.1177_10732748231202851-fig5.jpg

相似文献

1
A Predictive Model for the Early Death of Breast Cancer With Synchronous Liver Metastases: A Population-Based Study.具有同步肝转移的乳腺癌早期死亡的预测模型:一项基于人群的研究。
Cancer Control. 2023 Jan-Dec;30:10732748231202851. doi: 10.1177/10732748231202851.
2
An effective tool for predicting survival in breast cancer patients with lung metastasis: Nomograms constructed based on SEER.预测乳腺癌肺转移患者生存情况的有效工具:基于监测、流行病学与结果(SEER)构建的列线图
Front Surg. 2023 Jan 6;9:939132. doi: 10.3389/fsurg.2022.939132. eCollection 2022.
3
Risk and prognostic factors of breast cancer with liver metastases.乳腺癌肝转移的风险和预后因素。
BMC Cancer. 2021 Mar 6;21(1):238. doi: 10.1186/s12885-021-07968-5.
4
Receptor conversion and survival in breast cancer liver metastases.乳腺癌肝转移中的受体转化与存活。
Breast Cancer Res. 2023 Sep 13;25(1):105. doi: 10.1186/s13058-023-01706-4.
5
Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.新诊断的伴有肝转移的乳腺癌患者根据肿瘤亚型的预后因素及生存情况:一项竞争风险分析
Mol Clin Oncol. 2019 Sep;11(3):259-269. doi: 10.3892/mco.2019.1890. Epub 2019 Jul 1.
6
Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.年轻乳腺癌肝转移患者的风险因素和生存预测:一项基于人群的研究。
Front Endocrinol (Lausanne). 2023 Jun 23;14:1158759. doi: 10.3389/fendo.2023.1158759. eCollection 2023.
7
Web-Based Dynamic Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Breast Cancer Patients with Lung Metastases.用于预测伴有肺转移的乳腺癌患者总生存期和癌症特异性生存期的基于网络的动态列线图
J Pers Med. 2022 Dec 26;13(1):43. doi: 10.3390/jpm13010043.
8
A Nomogram for Predicting Survival in Patients With Breast Cancer Liver Metastasis: A Population-Based Study.预测乳腺癌肝转移患者生存情况的列线图:一项基于人群的研究
Front Oncol. 2021 Jun 2;11:600768. doi: 10.3389/fonc.2021.600768. eCollection 2021.
9
A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.基于乳腺癌患者临床病理特征分析的淋巴结阳性 Luminal B HER2 阴性亚型乳腺癌肝转移预测列线图
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221132669. doi: 10.1177/15330338221132669.
10
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.一种预测初诊转移性皮肤黑色素瘤患者癌症特异性死亡率的新型列线图和风险分类系统。
Ann Surg Oncol. 2021 Jul;28(7):3490-3500. doi: 10.1245/s10434-020-09341-5. Epub 2020 Nov 15.

引用本文的文献

1
Real-time survival assessment in breast cancer with liver metastasis.伴有肝转移的乳腺癌的实时生存评估
Discov Oncol. 2025 Jun 23;16(1):1184. doi: 10.1007/s12672-025-02999-x.
2
Synchronous multiple primary cancers involving cervical cancer and follicular lymphoma: A case report.同步发生的涉及宫颈癌和滤泡性淋巴瘤的多原发性癌:一例报告。
Oncol Lett. 2025 Feb 13;29(4):183. doi: 10.3892/ol.2025.14930. eCollection 2025 Apr.

本文引用的文献

1
Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205.Hsa_circ_0060467通过与eIF4A3结合并吸附miR-1205促进乳腺癌肝转移。
Cell Death Discov. 2023 May 9;9(1):153. doi: 10.1038/s41420-023-01448-4.
2
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases.替莫唑胺联合替西罗莫司治疗三阴性乳腺癌和结直肠癌肝转移的 Ib 期研究。
ESMO Open. 2023 Apr;8(2):100884. doi: 10.1016/j.esmoop.2023.100884. Epub 2023 Feb 28.
3
A machine learning-Based model to predict early death among bone metastatic breast cancer patients: A large cohort of 16,189 patients.
一种基于机器学习的模型,用于预测骨转移性乳腺癌患者的早期死亡:16189例患者的大型队列研究。
Front Cell Dev Biol. 2022 Dec 7;10:1059597. doi: 10.3389/fcell.2022.1059597. eCollection 2022.
4
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer.乳腺癌肝脑转移瘤内肿瘤异质性和免疫抑制微环境的单细胞景观
Adv Sci (Weinh). 2023 Feb;10(5):e2203699. doi: 10.1002/advs.202203699. Epub 2022 Dec 18.
5
A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.基于乳腺癌患者临床病理特征分析的淋巴结阳性 Luminal B HER2 阴性亚型乳腺癌肝转移预测列线图
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221132669. doi: 10.1177/15330338221132669.
6
The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition.FUS/circEZH2/KLF5 反馈环路通过增强上皮-间充质转化促进乳腺癌中 CXCR4 诱导的肝转移。
Mol Cancer. 2022 Oct 12;21(1):198. doi: 10.1186/s12943-022-01653-2.
7
The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin.环状 RNA ROBO1/Krüppel 样因子 5/FUS 反馈环路通过抑制 afadin 的选择性自噬来调节乳腺癌的肝转移。
Mol Cancer. 2022 Jan 24;21(1):29. doi: 10.1186/s12943-022-01498-9.
8
Social support and outcomes in older adults with lung cancer.老年人肺癌的社会支持与结局。
J Geriatr Oncol. 2022 Mar;13(2):214-219. doi: 10.1016/j.jgo.2021.09.009. Epub 2021 Oct 8.
9
Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study.明胶海绵微球联合吡柔比星经肝动脉化疗栓塞治疗乳腺癌肝转移的临床应用:单中心长期研究结果。
World J Surg Oncol. 2021 Aug 21;19(1):249. doi: 10.1186/s12957-021-02332-0.
10
Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies.乳腺癌脑转移:分子机制与治疗策略的深入探讨。
Br J Cancer. 2021 Oct;125(8):1056-1067. doi: 10.1038/s41416-021-01424-8. Epub 2021 Jul 5.